menu
    • menu

    Company profile for Northwest Biotherapeutics

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    EXCIPIENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the North America and Europe. The Company has a broad platform technology for DCVax® dendritic cell-based vaccines. The Company's lead program is ...
    Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the North America and Europe. The Company has a broad platform technology for DCVax® dendritic cell-based vaccines. The Company's lead program is a 331-patient Phase III trial of DCVax®-L for newly diagnosed Glioblastoma multiforme (GBM).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Northwest BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4800 Montgomery Lane Suite 800 Bethesda, MD 20814
    Telephone
    Telephone
    240-497-9024
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nwbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Northwest Biotherapeutics Builds 1st Grade C Suite in Sawston, UK
    Northwest Biotherapeutics Builds 1st Grade C Suite in Sawston, UK

    20 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-construction-activities-are-under-way-for-the-first-grade-c-manufacturing-suite-in-the-sawston-uk-facility-302622271.html

    PR NEWSWIRE
    20 Nov 2025
    Share Share
    Northwest Bio Acquires Advent Bioservices Ltd
    Northwest Bio Acquires Advent Bioservices Ltd

    25 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-that-its-acquisition-of-advent-bioservices-ltd-has-closed-302594108.html

    PR NEWSWIRE
    25 Oct 2025
    Share Share
    Northwest Biotherapeutics to Acquire Advent BioServices Ltd
    Northwest Biotherapeutics to Acquire Advent BioServices Ltd

    27 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-agreement-to-acquire-advent-bioservices-ltd-302540211.html

    PR NEWSWIRE
    27 Aug 2025
    Share Share
    Northwest Biotherapeutics Senior VP and General Counsel Mr. Les
    Northwest Biotherapeutics Senior VP and General Counsel Mr. Les

    18 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-the-passing-of-its-senior-vice-president-and-general-counsel-mr-les-goldman-302532451.html

    PR NEWSWIRE
    18 Aug 2025
    Share Share
    Northwest Biotherapeutics Reports Positive Annual Meeting Votes And Progress
    Northwest Biotherapeutics Reports Positive Annual Meeting Votes And Progress

    03 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-positive-votes-at-annual-meeting-reviews-strong-progress-and-growth-opportunities-302189064.html

    PR NEWSWIRE
    03 Jul 2024
    Share Share
    NW Bio In-Licenses Dendritic Cell Tech And IP Portfolio
    NW Bio In-Licenses Dendritic Cell Tech And IP Portfolio

    18 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169790&sid=2

    PHARMABIZ
    18 Jun 2024
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search